Free Trial

T2 Biosystems (TTOO) Competitors

T2 Biosystems logo
$0.12 0.00 (0.00%)
As of 07/11/2025 03:50 PM Eastern

TTOO vs. DHAI, WOK, PAVM, SSKN, NURO, CODX, BTCY, SINT, POAI, and TNON

Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include DIH Holding US (DHAI), WORK Medical Technology Group (WOK), PAVmed (PAVM), Strata Skin Sciences (SSKN), NeuroMetrix (NURO), Co-Diagnostics (CODX), Biotricity (BTCY), Sintx Technologies (SINT), Predictive Oncology (POAI), and Tenon Medical (TNON). These companies are all part of the "medical equipment" industry.

T2 Biosystems vs. Its Competitors

DIH Holding US (NASDAQ:DHAI) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

T2 Biosystems has a consensus price target of $5.00, indicating a potential upside of 3,900.00%. Given T2 Biosystems' stronger consensus rating and higher probable upside, analysts plainly believe T2 Biosystems is more favorable than DIH Holding US.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIH Holding US
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
T2 Biosystems
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

DIH Holding US has a net margin of -13.59% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
DIH Holding US-13.59% N/A -25.97%
T2 Biosystems -563.16%N/A -174.06%

DIH Holding US has higher revenue and earnings than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DIH Holding US$64.47M0.19-$8.44M-$0.30-0.86
T2 Biosystems$7.68M0.34-$50.08MN/AN/A

27.8% of DIH Holding US shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 49.6% of DIH Holding US shares are held by insiders. Comparatively, 0.0% of T2 Biosystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

DIH Holding US has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500.

In the previous week, DIH Holding US had 1 more articles in the media than T2 Biosystems. MarketBeat recorded 1 mentions for DIH Holding US and 0 mentions for T2 Biosystems. DIH Holding US's average media sentiment score of 1.89 beat T2 Biosystems' score of 0.00 indicating that DIH Holding US is being referred to more favorably in the media.

Company Overall Sentiment
DIH Holding US Very Positive
T2 Biosystems Neutral

Summary

DIH Holding US beats T2 Biosystems on 8 of the 12 factors compared between the two stocks.

Get T2 Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TTOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TTOO vs. The Competition

MetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2.63M$242.07M$5.61B$9.11B
Dividend YieldN/AN/A5.24%4.02%
P/E RatioN/A5.3127.9620.25
Price / Sales0.3465.41430.8999.65
Price / CashN/A196.1237.4658.16
Price / Book-0.026.138.045.49
Net Income-$50.08M-$26.64M$3.18B$250.27M
7 Day Performance-10.71%0.20%3.67%4.80%
1 Month Performance-10.78%-5.66%4.09%7.68%
1 Year Performance-97.72%23.29%29.58%16.36%

T2 Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TTOO
T2 Biosystems
2.2898 of 5 stars
$0.13
flat
$5.00
+3,900.0%
-97.5%$2.63M$7.68M0.00180Gap Down
DHAI
DIH Holding US
0.6692 of 5 stars
$0.25
+5.2%
N/A-92.2%$11.08M$64.47M-0.82N/APositive News
WOK
WORK Medical Technology Group
N/A$0.71
+0.1%
N/AN/A$10.36M$11.51M0.00226Gap Down
PAVM
PAVmed
4.4111 of 5 stars
$0.59
-1.2%
$19.00
+3,120.3%
-29.7%$10.21M$2.99M0.8390Positive News
SSKN
Strata Skin Sciences
3.3603 of 5 stars
$2.38
+2.1%
$6.00
+152.1%
-21.5%$9.72M$33.56M-1.05120High Trading Volume
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+24.7%$9.37M$3.03M-0.9920High Trading Volume
CODX
Co-Diagnostics
4.2355 of 5 stars
$0.26
-5.8%
$5.50
+2,007.3%
-80.8%$9.30M$3.91M-0.22100
BTCY
Biotricity
N/A$0.36
-14.3%
N/A-57.2%$8.97M$12.06M-0.3340Gap Up
SINT
Sintx Technologies
3.3208 of 5 stars
$3.26
-2.7%
$28.00
+758.9%
-39.3%$8.40M$2.89M-0.0640
POAI
Predictive Oncology
2.2339 of 5 stars
$0.85
0.0%
$3.00
+252.9%
-21.8%$7.59M$1.62M-0.2830News Coverage
TNON
Tenon Medical
1.8234 of 5 stars
$1.01
+2.5%
$4.67
+362.0%
+35.1%$7.48M$3.28M-0.048News Coverage

Related Companies and Tools


This page (NASDAQ:TTOO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners